Skip To Main Content

Flash e-reader
Choose a chapter:

Go to e-reader chapter

Table Selection
Choose an organ:

Choose a group:

Choose a characteristic:

Requires Adobe Acrobat Reader

Table 13.6c

Immunosuppression Use for Induction by Steroid Use at Discharge, 2005 to 2009

Recipients with Heart-Lung Transplants

	No Steroids Used for Maintenance		Steroids Used for Maintenance
	N	%	N	%
Functioning Graft with Immunosuppression Info at Discharge			125	100.0%
Induction Drugs
Atgam/NRATG/NRATS			18	14.4%
OKT3			1	0.8%
Thymoglobulin			4	3.2%
Zenapax			27	21.6%
Simulect			21	16.8%
Campath			16	12.8%
Rituximab			2	1.6%
No Induction Drug Reported			40	32.0%

Source: OPTN/SRTR Data as of October 1, 2010.

Includes patients with a functioning graft at discharge.

Steroids used for induction are not counted.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.